A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation

MLA

Fuentes, Rudy E., et al. “A Chimeric Platelet-Targeted Urokinase Prodrug Selectively Blocks New Thrombus Formation.” Journal of Clinical Investigation, Feb. 2016, p. 483. EBSCOhost, https://doi.org/10.1172/JCI81470.

APA

Fuentes, R. E., Zaitsev, S., Ahn, H. S., Hayes, V., Kowalska, M. A., Lambert, M. P., Wang, Y., Siegel, D. L., Bougie, D. W., Aster, R. H., Myers, D. D., Stepanova, V., Cines, D. B., Muzykantov, V. R., & Poncz, M. (2016). A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation. Journal of Clinical Investigation, 483. https://doi.org/10.1172/JCI81470.

Chicago

Fuentes, Rudy E., Sergei Zaitsev, Hyun Sook Ahn, Vincent Hayes, M. Anna Kowalska, Michele P. Lambert, Yuhuan Wang, et al. 2016. “A Chimeric Platelet-Targeted Urokinase Prodrug Selectively Blocks New Thrombus Formation.” Journal of Clinical Investigation, February, 483. doi:10.1172/JCI81470.